Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Eomesodermin-expressing T-helper cells are essential for chronic neuroinflammation.
Neuromyelitis Optica (NMO) with Abdominal Tuberculosis (TB).
Statistical image analysis of longitudinal RAVENS images.
Protoporphyrin Treatment Modulates Susceptibility to Experimental Autoimmune Encephalomyelitis in miR-155-Deficient Mice.
Oct4 transcription factor in conjunction with valproic acid accelerates myelin repair in demyelinated optic chiasm in mice.
In vivo imaging of human neuroinflammation.
Neurological disorders and celiac disease.
Functional and structural cerebral changes in key brain regions after a facilitation programme for episodic future thought in relapsing-remitting multiple sclerosis patients.
FTY720 sustains and restores neuronal function in the DA rat model of MOG-induced experimental autoimmune encephalomyelitis.
IL-17A activates ERK1/2 and enhances differentiation of oligodendrocyte progenitor cells.
Decreased levels of alpha-synuclein in cerebrospinal fluid of patients with clinically isolated syndrome and multiple sclerosis.
Physical therapy provision in multiple sclerosis across Europe: a regional lottery?
Genetic manipulation of microglia during brain development and disease.
Ozone Therapy in Ethidium Bromide-Induced Demyelination in Rats: Possible Protective Effect.
The Elderly Person With Multiple Sclerosis: Clinical Implications for the Increasing Life-Span.
Guillain Barré Syndrome in a multiple myeloma patient after the first course of bortezomib therapy: A case report.
Frequency, characteristics and consequences of falls in multiple sclerosis: findings from a cohort study.
Cortical plasticity predicts recovery from relapse in multiple sclerosis.
Comparison of Antioxidant Status and Vitamin D Levels between Multiple Sclerosis Patients and Healthy Matched Subjects.
Co-morbidities increase the risk of disability pension among MS patients: a population-based nationwide cohort study.
Numerical status of CD4(+)CD25(+)FoxP3(+) and CD8(+)CD28(-) regulatory T cells in multiple sclerosis.
Gavin Giovannoni on why time matters in multiple sclerosis.
Characteristics of Pediatric Patients With Relapsing Remitting Multiple Sclerosis Taking Disease Modifying Agents.
Cost-Effectiveness Analysis of Peginterferon Beta-1a In The Treatment of Relapsing-Remitting Multiple Sclerosis In Ireland.
Multi-Stage Mass Spectrometry Analysis of Sugar-Conjugated β-Turn Structures to be Used as Probes in Autoimmune Diseases.
Pages
« first
‹ previous
…
649
650
651
652
653
654
655
656
657
…
next ›
last »